所有心外膜冠状动脉开口闭塞:依靠旁路移植血管生存
该研究评估了165例既往CABG后右冠状动脉及左主干或等效左主干完全开口闭塞患者的临床特征与冠状动脉灌注。大多数患者有缺血或心衰症状,应激显像阳性常见,旁路血管通畅可维持生存,不同治疗方式的中位生存期存在差异。
要点
- 既往CABG患者可发生所有心外膜冠状动脉开口完全闭塞,通畅的旁路移植血管可维持生存。
- 应激PET显示多数患者存在缺血或瘢痕,完全血管化者占49%。
- 诊断后血运重建或药物治疗的选择与不同中位生存期相关。
核心结论
- 通畅的旁路移植血管可使患者在全部心外膜冠状动脉开口闭塞后仍维持生存,其他冠心病治疗未见此优势。
研究设计与样本
- 2009至2025年纳入165例既往CABG后右冠状动脉及左主干或左主干等效完全开口闭塞的成人,平均年龄72±9.8岁,92%为男性。
- 另1例无CABG史患者因心源性休克桥接至移植。
- 通过血管造影评估桥血管通畅性和侧支循环(Rentrop和侧支连接评分),应激正电子发射断层扫描(n=89)评估缺血和瘢痕负荷。
主要发现
- 165例中88例(53%)以缺血相关症状为主,67例(41%)以心衰相关症状为主,19例(12%)无症状。
- 89例中64例(72%)应激显像阳性。
- 64例有通畅左内乳动脉至左前降支且行PET的患者中,9例(14%)仅瘢痕,25例(39%)仅缺血,19例(30%)两者兼有。
- 侧支供应左前降支、回旋支和右冠状动脉区域分别为50、83和100例,其中左前降支侧支来自右冠状动脉者28/50(56%)。
- 233条侧支中103条(44%)为Rentrop 1级;81/165例(49%)达到完全血管化。
临床怎么用
- 对既往CABG患者应评估桥血管通畅性和侧支循环,以判断全部冠状动脉开口闭塞后的心肌灌注状态。
- 应激PET有助于识别缺血和瘢痕负荷,指导血运重建或药物管理决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate clinical profile and coronary perfusion of patients with ostial occlusion of all epicardial coronary arteries. METHODS: Between 2009 and 2025, 165 adults (mean age, 72 ± 9.8 years; 92% male [n = 152]) with prior coronary artery bypass grafting (CABG) had complete ostial occlusion of the right coronary artery (RCA) and either the left main (n = 120; 73%) or left main equivalent (n = 45; 27%). One additional patient without prior CABG presented in cardiogenic shock and was bridged to transplantation. Graft patency and collateralization (Rentrop and collateral connections scores) were assessed by angiography and ischemia, and scar burden was evaluated by stress positron emission tomography (n = 89). RESULTS: Of the 165 patients, 88 (53%) presented with symptoms related primarily to ischemia, 67 (41%) presented with symptoms related primarily to heart failure, and 19 (12%) were asymptomatic. Sixty-four of 89 patients (72%) had positive stress imaging. Of 64 patients with a patent internal thoracic artery to the left anterior descending artery (LAD) and had positron emission tomography tests, 9 (14%) showed scar only, 25 (39%) ischemia only, and 19 (30%) with both. Collaterals supplied the LAD, circumflex, and RCA territories in 50, 83, and 100 patients, respectively, with the LAD receiving collaterals from the RCA in 28 of the 50 (56%). The 233 collaterals included 103 (44%) with Rentrop grade 1 (filling without epicardial vessels); 81 of 165 patients (49%) had complete vascularization (patent grafts or high-grade collaterals to all territories). Postdiagnosis, 14 patients (8.4%) underwent CABG, 50 (30%) underwent percutaneous intervention, and 100 (61%) received medical management, with median survival of 7.6, 6.0, and 3.0 years, respectively (P = .027). CONCLUSIONS: Patent bypass grafts can sustain survival in patients even after ostial occlusion of all epicardial coronary arteries, an advantage not previously reported by other coronary disease therapies.
引用
- Awad AK, Young L, Alshneikat M, et al. Ostial occlusion of all epicardial coronary arteries: Living off bypass grafts. J Thorac Cardiovasc Surg. 2026. PMID: 42092511. doi:10.1016/j.jtcvs.2026.04.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。